A revised classification scheme for acute transfusion reactions

Transfusion

Volumn 47, Issue 4, 2007, Pages 621-628

  Sanders, Robert P ^a   Geiger, Terrence L ^b   Heddle, Nancy ^b   Pui, Ching Hon ^b   Howard, Scott C ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

ANAPHYLAXIS; BLOOD TRANSFUSION REACTION; CHILL; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEVER; HEMOLYSIS; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; INFLAMMATION; LEUKAPHERESIS; LUNG INFILTRATE; NOMENCLATURE; PLASMAPHERESIS; PRACTICE GUIDELINE; REVIEW; SEPSIS; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE DISEASE; ANAPHYLAXIS; BLOOD TRANSFUSION; FEVER; HUMANS; HYPERSENSITIVITY; RETROSPECTIVE STUDIES; SEPSIS;

EID: 33947392018     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01163.x     Document Type: Review

References (17)

1. Noninfectious complications of blood transfusion. In: Brecher ME, editor. Technical manual. Bethesda: American Association of Blood Banks; 2005. p. 633-66.
2. Perrotta PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev 2001;15:69-83.
3. Heddle NM. Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol 1999;6:420-6.
4. Gilstad CW. Anaphylactic transfusion reactions. Curr Opin Hematol 2003;10:419-23.
5. Pizzo PA, Robichaud KJ, Wesley R, Commers JR. Fever in the pediatric and young adult patient with cancer: a prospective study of 1001 episodes. Medicine (Baltimore) 1982;61:153-65.
6. Heddle NM, Constantini L, Meyer R, et al. Acute reactions to platelets: a new classification and interobserver reliability studies. Transfusion 1998;38(Suppl):40.
7. Heddle NM, Constantini L, Meyer R, et al. Face validity of a new classification for platelet reactions. Transfusion 1998;38(Suppl):42.
8. Common terminology criteria for adverse events v3.0 (CTCAE) [monograph on the Internet]. Rockville (MD): DCTD, NCI, NIH, DHHS; 2006 Aug 9. Available from: http://ctep.cancer.gov/forms/CTCAEv3.pdf
9. Goldman M, Webert KE, Arnold DM, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005;19:2-31.
10. Walsh TJ, Roilides E, Groll AH, et al. Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 1269-329.
11. Anaphylactic syndrome. In: Austen KF, Frank MM, Atkinson JP, Cantor H, editors. Samter's immunological diseases. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 825-36.
12. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004;114:371-6.
13. Uckan D, Dogan M, Karagoz T, Mizrak D, Cetin M. A long-lasting hypotensive reaction associated with leukocyte-filtered platelet transfusion in a post-bone marrow transplant patient with underlying severe cardiomyopathy. Pediatr Hematol Oncol 2003;20:531-3.
14. Yenicesu I, Tezcan I, Tuncer AM. Hypotensive reactions during platelet transfusions. Transfusion 1998;38:410-5.
15. Belloni M, Alghisi A, Bettini C, Soli M, Zampieri L. Hypotensive reactions associated with white cell-reduced apheresis platelet concentrates in patients not receiving ACE inhibitors. Transfusion 1998;38:412-5.
16. Williamson LM. Transfusion hazard reporting: powerful data, but do we know how best to use it? Transfusion 2002;42:1249-52.
17. Andreu G, Morel P, Forestier F, et al. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 2002;42:1356-64.